Compuestos de 1-oxo-1,2-dihidroisoquinolin-7-il-(tiofen-2-il-5-sustituido)-sulfonamida, formulaciones que contienen esos compuestos, y su uso como inhibidores de AICARFT en el tratamiento de cánceres
DURHAM, Timothy Barrett, TOTH, James Lee, MCCOWAN, Jefferson Ray, THRASHER, Kenneth Jeff, SI, Chong, FRIMPONG, Kwame, DALLY, Robert Dean, WU, Zhipei, SHEPHERD, Timothy Alan, FALES, Kevin Robert, NJOROGE, Frank George, BROOKS, Harold Burns
Year of Publication 28.06.2019
Get full text
Year of Publication 28.06.2019
Patent
compostos derivados de oxazol e oxadiazol e composições farmacêuticas úteis para a liberação oral de composto de peptídeo semelhante a glucagon-1 (glp-1) ou de peptídeo agonista de receptores de melatonina tipo 4 (mc4)
Kenneth Jeff Thrasher, Louis Nickolaus Jungheim, John McNeil McGill, III, Robert Jason Herr, Muralikrishna Valluri
Year of Publication 25.05.2021
Get full text
Year of Publication 25.05.2021
Patent
1-OXO-1,2-DIHYDROISOQUINOLIN-7-YL-(5-SUBSTITUTED-THIOPHEN-2-YL)-SULFONAMIDE COMPOUNDS, FORMULATIONS CONTAINING THOSE COMPOUNDS, AND THEIR USE AS AICARFT INHIBITORS IN THE TREATMENT OF CANCERS
DURHAM, Timothy Barrett, TOTH, James Lee, MCCOWAN, Jefferson Ray, THRASHER, Kenneth Jeff, SI, Chong, FRIMPONG, Kwame, DALLY, Robert Dean, WU, Zhipei, SHEPHERD, Timothy Alan, FALES, Kevin Robert, NJOROGE, Frank George, BROOKS, Harold Burns
Year of Publication 13.02.2019
Get full text
Year of Publication 13.02.2019
Patent
1-OXO-1,2-DIHYDROISOQUINOLIN-7-YL-(5-SUBSTITUTED-THIOPHEN-2-YL)-SULFONAMIDE COMPOUNDS, FORMULATIONS CONTAINING THOSE COMPOUNDS, AND THEIR USE AS AICARFT INHIBITORS IN THE TREATMENT OF CANCERS
DURHAM, Timothy Barrett, TOTH, James Lee, MCCOWAN, Jefferson Ray, THRASHER, Kenneth Jeff, SI, Chong, FRIMPONG, Kwame, DALLY, Robert Dean, WU, Zhipei, SHEPHERD, Timothy Alan, FALES, Kevin Robert, NJOROGE, Frank George, BROOKS, Harold Burns
Year of Publication 11.10.2017
Get full text
Year of Publication 11.10.2017
Patent
1-oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamide compounds, formulations containing those compounds, and their use as AICARFT inhibitors in the treatment of cancers
Brooks Harold Burns, Dally Robert Dean, Frimpong Kwame, Toth James Lee, Njoroge Frank George, Shepherd Timothy Alan, Si Chong, Fales Kevin Robert, McCowan Jefferson Ray, Wu Zhipei, Thrasher Kenneth Jeff, Durham Timothy Barrett
Year of Publication 03.10.2017
Get full text
Year of Publication 03.10.2017
Patent
1-OXO-1,2-DIHYDROISOQUINOLIN-7-YL-(5-SUBSTITUTED-THIOPHEN-2-YL)-SULFONAMIDE COMPOUNDS, FORMULATIONS CONTAINING THOSE COMPOUNDS, AND THEIR USE AS AICARFT INHIBITORS IN THE TREATMENT OF CANCERS
DALLY Robert Dean, WU Zhipei, NJOROGE Frank George, TOTH James Lee, DURHAM Timothy Barrett, THRASHER Kenneth Jeff, FALES Kevin Robert, SI Chong, MCCOWAN Jefferson Ray, FRIMPONG Kwame, SHEPHERD Timothy Alan, BROOKS Harold Burns
Year of Publication 17.08.2017
Get full text
Year of Publication 17.08.2017
Patent
COMPOUNDS, METHODS AND FORMULATIONS FOR THE ORAL DELIVERY OF A GLUCAGON-LIKE PEPTIDE (GLP-1) COMPOUND OR A MELANOCORTIN-4 RECEPTOR (MIC4) AGONIST PEPTIDE
HERR ROBERT JASON, MCGILL JOHN MCNEILL, JUNGHEIM LOUIS NICKOLAUS, VALLURI MURALIKRISHNA, THRASHER KENNETH JEFF
Year of Publication 30.01.2014
Get full text
Year of Publication 30.01.2014
Patent
Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide
HERR ROBERT JASON, MCGILL JOHN MCNEIL, JUNGHEIM LOUIS NICKOLAUS, VALLURI MURALIKRISHNA, THRASHER KENNETH JEFF
Year of Publication 08.10.2013
Get full text
Year of Publication 08.10.2013
Patent
Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (Glp)-1 compound or a melanocortin-4 receptor (Mc4) agonist peptide
HERR ROBERT JASON, JUNGHEIM LOUIS NICKOLAUS, VALLURI MURALIKRISHNA, MCGILL, III JOHN MCNEILL, THRASHER KENNETH JEFF
Year of Publication 01.10.2013
Get full text
Year of Publication 01.10.2013
Patent
1 -OXO-1,2-DIHYDROISOQUINOLIN-7-YL-(5-SUBSTITUTED-THIOPHEN-2-YL)-SULFONAMIDE COMPOUNDS, FORMULATIONS CONTAINING THOSE COMPOUNDS, AND THEIR USE AS AICARFT INHIBITORS IN THE TREATMENT OF CANCERS
SI, CHONG, DALLY, ROBERT DEAN, FRIMPONG, KWAME, NJOROGE, FRANK GEORGE, WU, ZHIPEI, BROOKS, HAROLD BURNS, MCCOWAN, JEFFERSON RAY, TOTH, JAMES LEE, THRASHER, KENNETH JEFF, DURHAM, TIMOTHY BARRETT, FALES, KEVIN ROBERT, SHEPHERD, TIMOTHY ALAN
Year of Publication 09.06.2016
Get full text
Year of Publication 09.06.2016
Patent
1 -OXO-1,2-DIHYDROISOQUINOLIN-7-YL-(5-SUBSTITUTED-THIOPHEN-2-YL)-SULFONAMIDE COMPOUNDS, FORMULATIONS CONTAINING THOSE COMPOUNDS, AND THEIR USE AS AICARFT INHIBITORS IN THE TREATMENT OF CANCERS
SI, CHONG, DALLY, ROBERT DEAN, FRIMPONG, KWAME, NJOROGE, FRANK GEORGE, WU, ZHIPEI, BROOKS, HAROLD BURNS, MCCOWAN, JEFFERSON RAY, TOTH, JAMES LEE, THRASHER, KENNETH JEFF, DURHAM, TIMOTHY BARRETT, FALES, KEVIN ROBERT, SHEPHERD, TIMOTHY ALAN
Year of Publication 09.06.2016
Get full text
Year of Publication 09.06.2016
Patent
compostos derivados de oxazol e oxadiazol e composições farmacêuticas úteis para a liberação oral de composto de peptídeo semelhante a glucagon-1 (glp-1) ou de peptídeo agonista de receptores de melatonina tipo 4 (mc4)
Kenneth Jeff Thrasher, Louis Nickolaus Jungheim, John McNeil McGill, III, Robert Jason Herr, Muralikrishna Valluri
Year of Publication 24.07.2018
Get full text
Year of Publication 24.07.2018
Patent
COMPOUNDS, METHODS AND FORMULATIONS FOR THE ORAL DELIVERY OF A GLUCAGON LIKE PEPTIDE (GLP)-1 COMPOUND OR AN MELANOCORTIN 4 RECEPTOR (MC4) AGONIST PEPTIDE
JUNGHEIM, LOUIS NICKOLAUS, HERR, ROBERT JASON, VALLURI, MURALIKRISHNA, MCGILL, JOHN MCNEILL, III, THRASHER, KENNETH JEFF
Year of Publication 25.09.2012
Get full text
Year of Publication 25.09.2012
Patent
COMPOUNDS, METHODS AND FORMULATIONS FOR THE ORAL DELIVERY OF A GLUCAGON LIKE PEPTIDE (GLP)-1 COMPOUND OR AN MELANOCORTIN 4 RECEPTOR (MC4) AGONIST PEPTIDE
JUNGHEIM, LOUIS NICKOLAUS, HERR, ROBERT JASON, MCGILL, JOHN MCNEILL III, VALLURI, MURALIKRISHNA, THRASHER, KENNETH JEFF
Year of Publication 17.04.2012
Get full text
Year of Publication 17.04.2012
Patent
COMPOUND, METHOD AND FORMULATION FOR ORAL DELIVERY OF GLUCAGON LIKE PEPTIDE (GLP)-1 COMPOUND OR MELANOCORTIN 4 RECEPTOR (MC4) AGONIST PEPTIDE
HERR ROBERT JASON, JUNGHEIM LOUIS NICKOLAUS, VALLURI MURALIKRISHNA, THRASHER KENNETH JEFF, MCGILL JOHN MCNEILL III
Year of Publication 20.10.2011
Get full text
Year of Publication 20.10.2011
Patent
Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide
HERR ROBERT JASON, JUNGHEIM LOUIS NICKOLAUS, VALLURI MURALIKRISHNA, MCGILL, III JOHN MCNEILL, THRASHER KENNETH JEFF
Year of Publication 04.08.2011
Get full text
Year of Publication 04.08.2011
Patent